Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2023 Earnings Call Transcript
Ginkgo Bioworks Holdings, Inc. reports earnings inline with expectations. Reported EPS is $-0.09 EPS, expectations were $-0.09. Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings Inc. (DNA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Anson Investments Amin Nathoo And Moez Kassam | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | ||
| 3. | Anson Investments Amin Nathoo And Moez Kassam | 0 | $0 | 0% | |
| 4. | Ghisallo Capital Management Michael Germino | 0 | $0 | 0% | |
| 5. | Davidson Kempner Thomas Lenox Kempner | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.28 | 400,000 | Director | 1,731,874 | 2023-05-18 | Filing | |
| $1.28 | 350,000 | Director | 420,921 | 2023-05-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.05 | 51,169 | Officer | 865,079 | 2024-04-02 | Filing | |
| $1.26 | 38,826 | Officer | 808,125 | 2024-03-04 | Filing | |
| $1.21 | 39,569 | Officer | 761,737 | 2024-02-02 | Filing | |
| $1.56 | 100,000 | Officer, Director | 3,894,680 | 2024-01-04 | Filing | |
| $1.54 | 100,000 | Officer, Director | 3,994,680 | 2024-01-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
12 Best NYSE Penny Stocks To Buy
Markets wavered as latest data showed inflation in January 2024 was hotter-than-expected.
5 Hot Healthcare Stocks To Buy Now
In this article, we will be taking a look at 5 hot healthcare stocks to buy now.
Ark Invest Stock Portfolio: 16 Biggest Positions
In this article, we discuss the 16 biggest positions in the ARK Invest portfolio.
12 Best Genomics Stocks To Buy Now
In this piece, we will take a look at the 12 best genomics stocks to buy now.
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q3 2023 Earnings Call Transcript
Megan LeDuc: Good evening. I'm Megan LeDuc, Manager of Investor Relations at Ginkgo Bioworks. I'm joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO.
15 Best ARK Stocks To Buy Now
Cathie Wood’s flagship ARK Innovation ETF made a roaring comeback earlier this year when investors’ risk appetite increased and growth stocks rebounded.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
5 Best High Risk Penny Stocks to Buy Now
Ranking 5th in our list of the best high risk penny stocks is Gossamer Bio, Inc. (NASDAQ:GOSS), a biopharma company working on treatments in immunology, inflammation, and oncology segments.
5 Best Biotech Penny Stocks to Buy Now
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) ranks 5th in our list of the best biotech penny stocks to buy now according to hedge funds. Ginkgo Bioworks Holdings, Inc.